Human medicines European public assessment report (EPAR): Iloperidone Vanda Pharmaceuticals, iloperidone, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR): Ponvory, ponesimod, Date of authorisation: 19/05/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Kengrexal, cangrelor, Date of authorisation: 23/03/2015, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Drovelis, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 9, Status: Authorised

Record of data processing activity for EudraVigilance

High-risk medical devices: consultation procedures

Class III implantable devices and Class IIb medical devices intended to administer or remove medicinal products: expert panel opinions

List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment

Human medicines European public assessment report (EPAR): Amversio, betaine anhydrous, Date of authorisation: 05/05/2022, Revision: 1, Status: Authorised